Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1997. MMWR Morb Mortal Wkly Rep.1998;46:ii-vii, 3-87.
Sigal LH, Patella SJ. Lyme arthritis as the incorrect diagnosis in pediatric and adolescent
Sigal LH. Anxiety and persistence of Lyme disease. Am J Med.1995;98:74S-78S.
Dinerman H, Steere AC. Lyme disease associated with fibromyalgia. Ann Intern Med.1992;117:281-285.
Hsu V, Patella SJ, Sigal LH. "Chronic Lyme disease" as the incorrect diagnosis in patients with
fibromyalgia. Arthritis Rheum.1993;36:1493-1500.
American College of Rheumatology and the Council of the Infectious
Diseases Society of America. Appropriateness of parenteral antibiotic treatment for patients with
presumed Lyme disease [comment]. Ann Intern Med.1993;119:518.
Lightfoot Jr RW, Luft BJ, Rahn DW.
et al. Empiric parenteral antibiotic treatment of patients with fibromyalgia
and fatigue and a positive serologic result for Lyme disease: a cost-effectiveness
analysis. Ann Intern Med.1993;119:503-509.
Shadick NA, Phillips CB, Logigian EL.
et al. The long-term clinical outcomes of Lyme disease: a population-based
retrospective cohort study. Ann Intern Med.1994;121:560-567.
Szer IS, Taylor E, Steere AC. The long-term course of Lyme arthritis in children. N Engl J Med.1991;325:159-163.
Petersen LR, Sweeney AH, Checko PJ.
et al. Epidemiological and clinical features of 1149 persons with Lyme disease
identified by laboratory-based surveillance in Connecticut. Yale J Biol Med.1989;62:253-262.
MacDonald KL, Osterholm MT, LeDell KH.
et al. A case-control study to assess possible triggers and cofactors in chronic
fatigue syndrome. Am J Med.1996;100:548-554.
Ware Jr JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36), I: conceptual framework
and item selection. Med Care.1992;30:473-483.
Sawyer-Radloff L. The CES-D Scale: a self-report depression scale for research in the
general population. Appl Psych Meas.1977;1:385-401.
Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep.1990;39(RR-13):19-21.
Mehta C, Patel N. StatXact [computer program]. Cambridge, Mass: Cytel Software; 1991.
Gustafson TL. True Epistat. 5th ed. Richardson, Tex: Epistat Services; 1994.
Selvin S. Statistical Analysis of Epidemiologic Data. 2nd ed. New York, NY: Oxford University Press; 1996:197-310.
Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL.for the Pediatric Lyme Disease Study Group. Lyme disease in children in Southeastern Connecticut. N Engl J Med.1996;335:1270-1274.
Sigal LH, Zahradnik JM, Lavin P.
et al. for the Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study
Consortium. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N Engl J Med.1998;339:216-222. [published correction appears in N Engl J Med. 1998;339:571].
Steere AC, Sikand VK, Meurice F.
et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med.1998;339:209-215.
Croft P, Rigby AS, Boswell R, Schollum J, Silman A. The prevalence of chronic widespread pain in the general population. J Rheumatol.1993;20:710-713.
Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA.1993;269:1812-1816.
Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease:
an observational study. Ann Intern Med.1998;128:354-362.
Rose CD, Fawcett PT, Gibney KM, Doughty RA. The overdiagnosis of Lyme disease in children residing in an endemic
area. Clin Pediatr (Phila).1994;33:663-668.
Adams WV, Rose CD, Eppes SC, Klein JD. Cognitive effects of Lyme disease in children: a 4 year followup study. J Rheumatol.1999;26:1190-1194.
Sigal LH. The Lyme disease controversy: social and financial costs of misdiagnosis
and mismanagement. Arch Intern Med.1996;156:1493-1500.
Sigal LH. Persisting complaints attributed to chronic Lyme disease: possible
mechanisms and implications for management. Am J Med.1994;96:365-374.
Gerber MA, Zemel LS, Shapiro ED. Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics.1998;102(4 pt 1):905-908.
Wang TJ, Sangha O, Phillips CB.
et al. Outcomes of children treated for Lyme disease. J Rheumatol.1998;25:2249-2253.
Itomaa M, Saxen H, Seppälä, I, Viljanen M, Pyykkö I. Paediatric facial paralysis caused by Lyme borreliosis: a prospective
and retrospective analysis. Scand J Infect Dis.1998;30:269-275.
Seltzer EG, Shapiro ED. Misdiagnosis of Lyme disease: when not to order serologic tests. Pediatr Infect Dis J.1996;15:762-763.
Bacterial Zoonoses Branch, Centers for Disease Control and Prevention. Evaluation of serologic tests for Lyme disease: report of a national
evaluation. Lyme Dis Surveill Summ.1991;2:1-3.
Burlington DB. FDA public health advisory: assays for antibodies to Borrelia burgdorferi: limitations, use, and interpretation for supporting
a clinical diagnosis of Lyme disease. Washington, DC: US Government Printing Office; July 7, 1997. Publication
Bakken LL, Callister SM, Wand PJ, Schell RF. Interlaboratory comparison of test results for detection of Lyme disease
by 516 participants in the Wisconsin State Laboratory of Hygiene/College of
American Pathologists Proficiency Testing Program. J Clin Microbiol.1997;35:537-543.
Schwartz BS, Goldstein MD, Ribeiro JM, Schulze TL, Shahied SI. Antibody testing in Lyme disease: a comparison of results in four laboratories. JAMA.1989;262:3431-3434.
Hedberg CW, Osterholm MT. Serologic tests for antibody to Borrelia burgdorferi: another Pandora's box for medicine [editorial]? Arch Intern Med.1990;150:732-733.
Tukey JW. Some thoughts on clinical trials, especially problems of multiplicity. Science.1977;198:679-684.
Gerber MA, Krause PJ, Badon SJ, Cartter ML. Prevalence of antibodies to Borrelia burgdorferi (Bb) and to Babesia microti (Bm) among blood
donors in Connecticut. Paper presented at: Fifth International Conference on Lyme Borreliosis;
May 30-June 2, 1992; Arlington, Va.
Shadick NA, Phillips CB, Sangha O.
et al. Musculoskeletal and neurologic outcomes in patients with previously
treated Lyme disease. Ann Intern Med.1999;131:919-926.
Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med.1990;323:1438-1444.
Steere AC, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med.1990;323:219-223. [published correction appears in N Engl J Med. 1991;324:129].
Gross DM, Forsthuber T, Tary-Lehmann M.
et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant
Lyme arthritis. Science.1998;281:703-706.